PIL Readability Testing is Mandatory in EAEUFebruary 15, 2022
Inpharmatis became the winner of the tender for PIL Readability User Testing according to the EAEU requirements for NPO “Microgen”
Inpharmatis became the winner of the tender for PIL Readability User Testing according to the EAEU requirements for NPO “Microgen”.
This is a mandatory procedure in registering a new medicine or bringing the registration dossier in line with the EAEU requirements. PIL Readability User Testing is conducted to ensure readability, clarity, and ease of comprehension of the information in the package insert. Well-conducted Testing allows the majority of medicine users to make safe and correct decisions.
Requirements for the contents are contained in the Decision of the EEC Council No. 88 and Decision of the EEC Council No. 78.
Inpharmatis has high expertise and proven practical experience in conducting high-quality PIL Readability User Testing in accordance with the requirements of the EAEU. Testing results have been successfully accepted by the regulatory authorities and received 100% approval.
Пользовательское тестирование по ЕАЭС – обязательная процедураFebruary 14, 2022
One More Inpharmatis Team Member Gets PhD in Pharmaceutical SciencesJanuary 27, 2022
В штате Inpharmatis стало на одного доктора фармацевтических наук большеJanuary 27, 2022
Pharma 4.0: Data-Driven RegulationJanuary 18, 2022
Pharma 4.0: от управления на основе документов к решениям, основанным на данныхJanuary 18, 2022
New Inpharmatis Russian Office Phone NumberJanuary 05, 2022
Изменение контактных данных российского офиса InpharmatisJanuary 05, 2022
Inpharmatis Team Participated in the Russian Healthcare ForumDecember 16, 2021
Inpharmatis принял участие в работе форума «Российская неделя здравоохранения»December 16, 2021